Publications View
Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6.
Authors: Authors: Machado FS, Esper L, Dias A, Madan R, Gu Y, Hildeman D, Serhan CN, Karp CL, Aliberti J.
J Exp Med
View full abstract on Pubmed
J Exp Med
View full abstract on Pubmed
Native and aspirin-triggered lipoxins control innate immunity by inducing proteasomal degradation of TRAF6.
Authors: Authors: Machado FS, Esper L, Dias A, Madan R, Gu Y, Hildeman D, Serhan CN, Karp CL, Aliberti J.
J Exp Med
View full abstract on Pubmed
J Exp Med
View full abstract on Pubmed
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators.
Anesthetics impact the resolution of inflammation.
Authors: Authors: Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN.
PLoS One
View full abstract on Pubmed
PLoS One
View full abstract on Pubmed
Anesthetics impact the resolution of inflammation.
Authors: Authors: Chiang N, Schwab JM, Fredman G, Kasuga K, Gelman S, Serhan CN.
PLoS One
View full abstract on Pubmed
PLoS One
View full abstract on Pubmed
Resolvin E1 metabolome in local inactivation during inflammation-resolution.
Authors: Authors: Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN.
J Immunol
View full abstract on Pubmed
J Immunol
View full abstract on Pubmed
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.
Resolvin E1 metabolome in local inactivation during inflammation-resolution.
Authors: Authors: Hong S, Porter TF, Lu Y, Oh SF, Pillai PS, Serhan CN.
J Immunol
View full abstract on Pubmed
J Immunol
View full abstract on Pubmed
Endogenous pro-resolving and anti-inflammatory lipid mediators: a new pharmacologic genus.